Уважаемые пользователи!
Мы рады представить вам новую версию сайта с улучшенным интерфейсом и новыми возможностями.
Приглашаем вас ознакомиться и поделиться обратной связью. Спасибо, что вы с нами!
Попробовать!

Reduced kidney function and anemia as risk factors for new onset AF

05.09.20131932
Each of chronic kidney disease (CKD) and anemia is a potential independent risk factor for cardiovascular disease (CVD); however, reduced kidney function, anemia, and its relationship have not been fully evaluated for the incidence of atrial fibrillation (AF).

Gender Data Forum: Are DES Safer and More Effective Than Bare Metal Stents in Women?

04.09.20131619
The use of drug-eluting stents (DES) in women is more effective and safe than using bare-metal stents during long-term follow-up, according to a study released on Sept. 2 during the ESC Congress 2013 and simultaneously published in The Lancet.

RAFT: Beta Blocker Therapy in Congestive Heart Failure Patients With LVEF

03.09.20131858
Use of beta blocker therapy to treat congestive heart failure (CHF) patients with reduced left ventricular ejection fraction (LVEF) remains paramount, with benefits independent of those of newer CHF therapies, according to results of the RAFT Study presented on Sept. 2 during the ESC Congress 2013.

Randomized Trial of Preventive Angioplasty in Myocardial Infarction

02.09.20131901
In acute ST-segment elevation myocardial infarction (STEMI), the use of percutaneous coronary intervention (PCI) to treat the artery responsible for the infarct (infarct, or culprit, artery) improves prognosis.

Macitentan Cuts Morbidity, Death in Pulmonary Arterial HTN

30.08.20132087
For patients with pulmonary arterial hypertension, the new dual endothelin-receptor antagonist macitentan is associated with reductions in morbidity and mortality, according to a study published in the Aug. 29 issue of the New England Journal of Medicine.

Uric acid and risk of heart failure: a systematic review and meta-analysis

29.08.20132080
We aimed to perform a systematic review and meta-analysis to assess the association between serum uric acid and incident heart failure (HF)/prognosis of HF patients.

The 6-minute walking test and all-cause mortality in patients undergoing a post-cardiac surgery rehabilitation program

28.08.20131764
The 6-minute walking test (6mWT) is used to prescribe physical activity in cardiac surgery patients. The clinical value of a pre-discharge 6mWT and its association with outcome is not well defined.
Данный сайт и вся информация на нём предназначена для медицинских работников. Продолжая просмотр, вы соглашаетесь и подтверждаете, что являетесь медицинским работником.